跳至主要内容
临床试验/JPRN-UMIN000018311
JPRN-UMIN000018311已完成未知

The effect of trelagliptin on vascular endothelial functions in patients with type II diabetes mellitus. - The effect of trelagliptin on vascular endothelial functions in patients with type II diabetes mellitus.

Ise Red Cross Hospital Department of Metabolic Diseases0 个研究点目标入组 30 人开始时间: 2015年7月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) type 1 diabetes 2) secondary diabetes 3) Patients receiving insulin or GLP-1 analogue therapy 4) Poor-controlled diabetes (HbA1c>10.0 % or fasting blood glucose levels greater than 250mg/dl) 5) History of stroke, acute coronary syndrome or any cardiovascular diseases needed for inpatient-treatments within 6 months 6) Either level of aspartate aminotransaminase or alanine aminotransferase exceed three-fold of the normal limits 7) renal insufficiency: serum creatinine>1.5 8) Malignancies or other diseases with poor prognosis 9) Pregnant 10) Subjects whose doctor in charge do not agree to join the trial

研究者

发起方
Ise Red Cross Hospital Department of Metabolic Diseases

相似试验